We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CorMedix Inc | AMEX:CRMD | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.90 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * Dillione Janet | 2. Issuer Name and Ticker or Trading Symbol CorMedix Inc. [ CRMD ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 53473.0000 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Phantom Stock | $0.0000 | 11/16/2020 | A | 3583.0000 | (1) | (1) | Common Stock | 3583.0000 | $0.0000 | 3583.0000 | D | ||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 4770.0000 | 4770.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 5253.0000 | 5253.0000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $5.6300 | (2) | 2/25/2030 | Common Stock | 15000.0000 | 15000.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 1706.0000 | 1706.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 2099.0000 | 2099.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 945.0000 | 945.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 1126.0000 | 1126.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 843.0000 | 843.0000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $8.3000 | (3) | 1/10/2029 | Common Stock | 15000.0000 | 15000.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 1328.0000 | 1328.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 2728.0000 | 2728.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 7500.0000 | 7500.0000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $2.8500 | (4) | 2/16/2028 | Common Stock | 8000.0000 | 8000.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 2679.0000 | 2679.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 3125.0000 | 3125.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 4167.0000 | 4167.0000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $11.2000 | (5) | 2/21/2027 | Common Stock | 8000.0000 | 8000.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 695.0000 | 695.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 829.0000 | 829.0000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $15.1500 | (6) | 8/11/2025 | Common Stock | 10000.0000 | 10000.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 283.0000 | 283.0000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $9.5500 | (7) | 2/21/2026 | Common Stock | 19000.0000 | 19000.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 767.0000 | 767.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 554.0000 | 554.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 867.0000 | 867.0000 | D | ||||||||
Phantom Stock | $0.0000 | (1) | (1) | Common Stock | 3062.0000 | 3062.0000 | D |
Remarks: The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Dillione Janet C/O CORMEDIX INC. 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS, NJ 07922 | X |
Signatures | ||
/s/ Janet Dillione | 11/18/2020 | |
**Signature of Reporting Person | Date |
1 Year CorMedix Chart |
1 Month CorMedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions